European markets are slightly higher
European stock indices flew higher this morning, but not by enough to undo yesterday’s sharp losses. Today’s rally follows a volatile session in which the DAX gave up a 250-point intraday gain to finish 250 points lower.
Investors reacted positively to news that an EU-US trade deal had been agreed upon so quickly and that the EU tariff was 15% rather than the 30% initially threatened. However, some criticism came from individual countries, most notably from France and Germany, suggesting that the European Commission (EC), led by Ursula von der Leyen, had effectively rolled over.
After all, a 15% tariff is significantly above the effective 1% levy that existed at the beginning of the year. In addition, the EC has promised to invest around $600 billion in the US and purchase US-liquefied natural gas.
Source: TN Trader
But investors have used yesterday’s sell-off as an opportunity to increase their exposure to European equities, encouraged no doubt by this morning’s bounce in US stock index futures.
In addition, AstraZeneca released an impressive set of earnings this morning. The company beat both revenue and earnings estimates, reporting $14.46 billion in second-quarter sales and an adjusted core operating profit of $4.58 billion.
The pharma giant maintained its full-year forecast and reiterated long-term goals, including a bold revenue target of $80 billion by 2030 - with a clear push toward US market expansion.